Jingwen Ma

Jingwen Ma

Auto-generated profile, based on publicly available information

Jingwen Ma

Northwest Women’s and Children’s Hospital

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 June 2023 in Exploration
Verified
Journal Article
Open access
JMJingwen Ma
Jingwen Ma
NLNa Li
Na Li
JWJingjian Wang
Jingjian Wang
ZLZhe Liu
Zhe Liu
YHYulong Han
Yulong Han
YZYun Zeng
Yun Zeng
Tumor cells may be eliminated by increasing their temperature. This is achieved via photothermal therapy (PTT) by penetrating the tumor tissue with near‐infrared light and converting light energy into heat using photothermal agents. Copper sulfide nanoparticles (CuS NPs) are commonly used as PTAs in PTT. In this review, we aimed to discuss the synergism between tumor PTT with CuS NPs and other therapies such as chemotherapy, radiotherapy, dynamic therapies (photodynamic, chemodynamic, and sonodynamic therapy), immunotherapy, gene therapy, gas therapy, and magnetic hyperthermia. Furthermore, we summarized the results obtained with a combination of two treatments and at least two therapies, with PTT as one of the included therapies. Finally, we summarized the benefits and drawbacks of various therapeutic options and state of the art CuS‐based PTT and provided future directions for such therapies.

30 June 2022 in Advanced Science
Verified
Journal Article
Open access
YZYun Zeng
Yun Zeng
TDTaotao Dou
Taotao Dou
LMLei Ma
Lei Ma
JMJingwen Ma
Jingwen Ma
Photoacoustic (PA) imaging is a nonionizing, noninvasive imaging technique that combines optical and ultrasonic imaging modalities to provide images with excellent contrast, spatial resolution, and penetration depth. Exogenous PA contrast agents are created to increase the sensitivity and specificity of PA imaging and to offer diagnostic information for illnesses. The existing PA contrast agents are categorized into two groups in this review: “always‐on” and “turn‐on,” based on their ability to be triggered by target molecules. The present state of these probes, their merits and limitations, and their future development, is explored.

26 June 2024 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
PCPeng Chang
Peng Chang
YGYingying Guo
Yingying Guo
DCDan Chen
Dan Chen
KLKe Li
Ke Li
WWWei Wang
Wei Wang
YZYonghua Zhan
Yonghua Zhan
Background: Hypoxia-activated prodrugs present new opportunities for safe and effective tumor drug resistance therapy due to their high selectivity for hypoxic cells. However, the uneven distribution of oxygen in solid tumor and insufficient hypoxia in the tumor microenvironment greatly limit its therapeutic efficacy. Results: In this paper, a novel AQ4N-Mn(II)@PDA coordination nanoplatform was designed and functionalized with GMBP1 to target drug-resistant tumor cells. Its excellent photothermal conversion efficiency could achieve local high-temperature photothermal therapy in tumors, which could not only effectively exacerbate tumor hypoxia and thus improve the efficacy of hypoxia-activated chemotherapy of AQ4N but also significantly accelerate Mn2+-mediated Fenton-like activity to enhance chemodynamic therapy. Moreover, real-time monitoring of blood oxygen saturation through photoacoustic imaging could reflect the hypoxic status of tumors during treatment. Furthermore, synergistic treatment effectively inhibited tumor growth and improved the survival rate of mice bearing orthotopic drug-resistant tumors. Conclusions: This study not only provided a new idea for PTT combined with hypoxia-activated chemotherapy and CDT for drug-resistant tumors but also explored a vital theory for real-time monitoring of hypoxia during treatment.

26 April 2023 in Small
Verified
Journal Article
Closed access
YZYun Zeng
Yun Zeng
HLHuifang Liu
Huifang Liu
JMJingwen Ma
Jingwen Ma
KLKe Li
Ke Li
PCPeng Chang
Peng Chang
YZYonghua Zhan
Yonghua Zhan

27 August 2026 in ACS Applied Nano Materials
Verified
Journal Article
Closed access
JMJingwen Ma
Jingwen Ma
YZYun Zeng
Yun Zeng
XWXiaoye Wang
Xiaoye Wang
YLYuan Liu
Yuan Liu
DXDan Xiao
Dan Xiao
RQRong Qiang
Rong Qiang